Terminated
High Dose IL-2 in Combination With Anti-PD-1
NCT03991130
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States